MDxHealth SA (MDXH) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering MDxHealth SA (MDXH), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For MDxHealth SA, analysts forecast revenue rising from $88.62M in 2024 to $133.00M in 2029; the average estimate for 2029 earnings per share is −$0.12; with published estimates ranging from −$0.13 to −$0.11; 4 analysts contribute to these figures. These are forecasts published by analysts, not results.
Analyst price targets
A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
MDxHealth SA (MDXH) forecast — frequently asked questions
What is the analyst price target for MDxHealth SA?
Analysts covering MDxHealth SA (MDXH) have a consensus price target of $2.50, 1566.7% above the current price of $0.15. Published targets range from $2.00 to $3.00. A price target is a forecast, not a measure of value, and targets are revised often.
What are analysts forecasting for MDxHealth SA's earnings?
The average analyst estimate for MDxHealth SA (MDXH) earnings per share in 2029 is -0.12, with individual estimates between -0.13 and -0.11.
How much revenue is MDxHealth SA expected to make?
Analysts forecast MDxHealth SA (MDXH) revenue of $133.00M in 2029, based on 1 published estimates.
How many analysts cover MDXH?
4 analysts contribute estimates for MDxHealth SA (MDXH). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Diagnostics & Research stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.